This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Braaten, D. Articles by Luban, J. Search for Related Content PubMed PubMed Citation Articles by Braaten, D. Articles by Luban, J.

 Previous Article  |  Next Article 

J. Virol., Mar 1997, 2107-2113, Vol 71, No. 3
Copyright © 1997, American Society for Microbiology

The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein

D Braaten, H Ansari and J Luban
Department of Microbiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

Completion of an early step in the human immunodeficiency virus type 1 (HIV-1) life cycle requires incorporation into virions of the cellular peptidyl-prolyl isomerase cyclophilin A (CyPA) by the Gag polyprotein. Elucidation of the biochemical role of CyPA would be aided by a detailed analysis of the genetic requirements for the formation of the Gag-CyPA complex; previous experiments have demonstrated the requirement for a critical proline and the immediately preceding glycine, located within the capsid domain of Gag, but nothing is known about the necessary CyPA residues. Cyclophilins possess a hydrophobic pocket where proline-containing peptide substrates and the immunosuppressive drug cyclosporine A bind. In this study, we engineered five CyPA mutations, each of which alters a residue that contributes to the hydrophobic pocket. Compared with the wild-type protein, all of the mutants drastically reduced CyPA binding to HIV-1 Gag and similarly inhibited CyPA incorporation into virions. In addition, we demonstrated that previously reported differences between the Gag-binding properties of CyPA and CyPB are due to adventitious association involving residues in the signal sequence of CyPB and that the core domain of CyPB interacts with Gag in a fashion which is indistinguishable from that of CyPA. These studies indicate that, as with other proline-containing peptides or cyclosporine A, HIV-1 Gag directly contacts residues in the hydrophobic pocket of CyPA.

This article has been cited by other articles:

• Yang, F., Robotham, J. M., Nelson, H. B., Irsigler, A., Kenworthy, R., Tang, H. (2008). Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro. J. Virol. 82: 5269-5278 [Abstract] [Full Text]  
• Brennan, G., Kozyrev, Y., Hu, S.-L. (2008). From the Cover: TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl. Acad. Sci. USA 105: 3569-3574 [Abstract] [Full Text]  
• Chatterji, U., Bobardt, M. D., Stanfield, R., Ptak, R. G., Pallansch, L. A., Ward, P. A., Jones, M. J., Stoddart, C. A., Scalfaro, P., Dumont, J.-M., Besseghir, K., Rosenwirth, B., Gallay, P. A. (2005). Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey Cells. J. Biol. Chem. 280: 40293-40300 [Abstract] [Full Text]  
• Ribeiro, I. P., Menezes, A. N., Moreira, M. A. M., Bonvicino, C. R., Seuanez, H. N., Soares, M. A. (2005). Evolution of Cyclophilin A and TRIMCyp Retrotransposition in New World Primates. J. Virol. 79: 14998-15003 [Abstract] [Full Text]  
• Cantin, R., Methot, S., Tremblay, M. J. (2005). Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses. J. Virol. 79: 6577-6587 [Full Text]  
• Arevalo-Rodriguez, M., Heitman, J. (2005). Cyclophilin A Is Localized to the Nucleus and Controls Meiosis in Saccharomyces cerevisiae. Eukaryot Cell 4: 17-29 [Abstract] [Full Text]  
• Sokolskaja, E., Sayah, D. M., Luban, J. (2004). Target Cell Cyclophilin A Modulates Human Immunodeficiency Virus Type 1 Infectivity. J. Virol. 78: 12800-12808 [Abstract] [Full Text]  
• Zander, K., Sherman, M. P., Tessmer, U., Bruns, K., Wray, V., Prechtel, A. T., Schubert, E., Henklein, P., Luban, J., Neidleman, J., Greene, W. C., Schubert, U. (2003). Cyclophilin A Interacts with HIV-1 Vpr and Is Required for Its Functional Expression. J. Biol. Chem. 278: 43202-43213 [Abstract] [Full Text]  
• Ingelfinger, D., Gothel, S. F., Marahiel, M. A., Reidt, U., Ficner, R., Luhrmann, R., Achsel, T. (2003). Two protein-protein interaction sites on the spliceosome-associated human cyclophilin CypH. Nucleic Acids Res 31: 4791-4796 [Abstract] [Full Text]  
• Ansari, H., Greco, G., Luban, J. (2002). Cyclophilin A Peptidyl-Prolyl Isomerase Activity Promotes Zpr1 Nuclear Export. Mol. Cell. Biol. 22: 6993-7003 [Abstract] [Full Text]  
• Yurchenko, V., Zybarth, G., O'Connor, M., Dai, W. W., Franchin, G., Hao, T., Guo, H., Hung, H.-C., Toole, B., Gallay, P., Sherry, B., Bukrinsky, M. (2002). Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147. J. Biol. Chem. 277: 22959-22965 [Abstract] [Full Text]  
• Bosco, D. A., Eisenmesser, E. Z., Pochapsky, S., Sundquist, W. I., Kern, D. (2002). Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. USA 99: 5247-5252 [Abstract] [Full Text]  
• Saphire, A. C. S., Bobardt, M. D., Gallay, P. A. (2002). Cyclophilin A Plays Distinct Roles in Human Immunodeficiency Virus Type 1 Entry and Postentry Events, as Revealed by Spinoculation. J. Virol. 76: 4671-4677 [Abstract] [Full Text]  
• Saphire, A. C. S., Bobardt, M. D., Gallay, P. A. (2002). trans-Complementation Rescue of Cyclophilin A-Deficient Viruses Reveals that the Requirement for Cyclophilin A in Human Immunodeficiency Virus Type 1 Replication Is Independent of Its Isomerase Activity. J. Virol. 76: 2255-2262 [Abstract] [Full Text]  
• Fujita, M., Yoshida, A., Miyaura, M., Sakurai, A., Akari, H., Koyama, A. H., Adachi, A. (2001). Cyclophilin A-Independent Replication of a Human Immunodeficiency Virus Type 1 Isolate Carrying a Small Portion of the Simian Immunodeficiency Virus SIVMAC gag Capsid Region. J. Virol. 75: 10527-10531 [Abstract] [Full Text]  
• Dietrich, L., Ehrlich, L. S., LaGrassa, T. J., Ebbets-Reed, D., Carter, C. (2001). Structural Consequences of Cyclophilin A Binding on Maturational Refolding in Human Immunodeficiency Virus Type 1 Capsid Protein. J. Virol. 75: 4721-4733 [Abstract] [Full Text]  
• Yin, L., Braaten, D., Luban, J. (1998). Human Immunodeficiency Virus Type 1 Replication Is Modulated by Host Cyclophilin A Expression Levels. J. Virol. 72: 6430-6436 [Abstract] [Full Text]  
• Kong, L. B., An, D., Ackerson, B., Canon, J., Rey, O., Chen, I. S. Y., Krogstad, P., Stewart, P. L. (1998). Cryoelectron Microscopic Examination of Human Immunodeficiency Virus Type 1 Virions with Mutations in the Cyclophilin A Binding Loop. J. Virol. 72: 4403-4407 [Abstract] [Full Text]  
• Dolinski, K., Muir, S., Cardenas, M., Heitman, J. (1997). All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in cerevisiae. Proc. Natl. Acad. Sci. USA 94: 13093-13098 [Abstract] [Full Text]  
• Dolinski, K., Scholz, C., Muir, R. S., Rospert, S., Schmid, F. X., Cardenas, M. E., Heitman, J. (1997). Functions of FKBP12 and Mitochondrial Cyclophilin Active Site Residues In Vitro and In Vivo in Saccharomyces cerevisiae. Mol. Biol. Cell 8: 2267-2280 [Abstract] [Full Text]  
• Bosco, D. A., Eisenmesser, E. Z., Pochapsky, S., Sundquist, W. I., Kern, D. (2002). Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. USA 99: 5247-5252 [Abstract] [Full Text]